homocysteine and Coronary Restenosis

homocysteine has been researched along with Coronary Restenosis in 28 studies

Research

Studies (28)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's25 (89.29)29.6817
2010's3 (10.71)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chang, FJ; Chen, HC; Cheng, G; Han, WQ; Min, ZQ; Wang, JW; Wang, Y; You, PH; Zhong, NE1
Chen, X; Hu, X; Xiao, S; Yang, C; Ye, R; Zhang, Z1
Garcia, S; Goldman, S; Larsen, GC; Littooy, F; McFalls, EO; Moritz, TE; Murray, ST; Pierpont, G; Ward, HB1
Doolman, R; Freimark, D; Goldenberg, I; Guetta, V; Hod, H; Hodish, I; Matetzky, S; Sela, BA; Selah, BA1
Ambrose, JA; Bilianou, HI; DeVoe, MC; Fakiolas, CN; Foussas, SG; Manousakis, SJ; Olympios, CD; Papadaki, OA; Pissimissis, EG; Stefanidis, AS; Zairis, MN1
Eberli, FR; Flammer, Y; Hess, OM; Meier, B; Pin, R; Roffi, M; Schnyder, G; Turi, ZG1
Rouvinez, G; Schnyder, G1
Braun, S; Burghartz, M; Kastrati, A; Koch, W; Kölling, K; Lengnick, H; Mehilli, J; Ndrepepa, G; Schömig, A1
Aharonian, VJ; Burchette, RJ; Jorgensen, MB; Kojoglanian, SA; Wolde-Tsadik, G1
Bilo, G; Bryniarski, L; Curyło, A; Jankowski, P; Kawecka-Jaszcz, K; Styczkiewicz, K1
de Lorgeril, M; Salen, P1
Ambrosi, P1
Börner, C; Dambrink, JH; De Luca, G; Dille, J; Kallmayer, K; Lange, H; Pasalary, MN; Scherer, E; Suryapranata, H1
Fowler, B; Herrmann, W; Stanger, O1
Stanger, O1
Chiariello, M; De Luca, G; Gregorio, G; Lange, H; Suryapranata, H1
Baumgart, D; Beckert, J; Breuckmann, F; Erbel, R; Haude, M; Naber, C; Schmermund, A1
Motamedi, MR; Namazi, MH; Nazari, N; Saadat, H; Safi, M; Vakili, H1
Hayakawa, T; Kamiya, H; Kondo, J; Kosokabe, T; Matsui, H; Mukawa, H; Okumura, K; Sone, T; Suzuki, T; Tomida, T; Tsuboi, H1
Selzman, CH1
Gillespie, JI; Hansrani, M; Stansby, G1
Eberli, FR; Flammer, Y; Hess, OM; Lange, H; Meier, B; Pin, R; Roffi, M; Schnyder, G; Turi, ZG1
Elmadfa, I; Genser, D; Halbmayer, WM; Hauer, R; Mlczoch, J; Prachar, H1
Flammer, Y; Hess, OM; Pin, R; Roffi, M; Schnyder, G1
Kangkagate, C; Leowattana, W; Lolekha, P; Mahanonda, N; Pokum, S1

Reviews

7 review(s) available for homocysteine and Coronary Restenosis

ArticleYear
Association of Elevated Plasma Homocysteine Level with Restenosis and Clinical Outcomes After Percutaneous Coronary Interventions: a Systemic Review and Meta-analysis.
    Cardiovascular drugs and therapy, 2019, Volume: 33, Issue:3

    Topics: Adult; Aged; Biomarkers; Coronary Restenosis; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Percutaneous Coronary Intervention; Risk Assessment; Risk Factors; Stents; Treatment Outcome; Up-Regulation

2019
Total plasma homocysteine and restenosis after percutaneous coronary angioplasty: current evidence.
    Annals of medicine, 2003, Volume: 35, Issue:3

    Topics: Angioplasty, Balloon, Coronary; Biomarkers; Coronary Restenosis; Folic Acid; Homocysteine; Humans; Risk Assessment; Risk Factors; Treatment Outcome; Vitamin B 12; Vitamin B 6

2003
[Is homocysteine a new factor in the pathogenesis of restenosis after percutaneous coronary angioplasty?].
    Przeglad lekarski, 2003, Volume: 60, Issue:8

    Topics: Angioplasty, Balloon, Coronary; Coronary Restenosis; Homocysteine; Humans; Postoperative Complications

2003
Homocysteine and post-angioplasty restenosis.
    Nutrition, metabolism, and cardiovascular diseases : NMCD, 2003, Volume: 13, Issue:6

    Topics: Angioplasty, Balloon, Coronary; Coronary Restenosis; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Postoperative Complications; Risk Factors

2003
The potential role of homocysteine in percutaneous coronary interventions (PCI): review of current evidence and plausibility of action.
    Cellular and molecular biology (Noisy-le-Grand, France), 2004, Volume: 50, Issue:8

    Topics: Adult; Aged; Angioplasty; Angioplasty, Balloon, Coronary; Animals; Clinical Trials as Topic; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Coronary Stenosis; Endothelium, Vascular; Female; Homocysteine; Homozygote; Humans; Hyperhomocysteinemia; Male; Middle Aged; Models, Biological; Risk; Risk Factors; Vitamin B Complex

2004
Current approaches to therapy for vascular injury.
    Expert opinion on pharmacotherapy, 2001, Volume: 2, Issue:5

    Topics: Anti-Bacterial Agents; Arteriosclerosis; Bacterial Infections; Coronary Restenosis; Folic Acid; Homocysteine; Humans; Macrolides

2001
Homocysteine in myointimal hyperplasia.
    European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery, 2002, Volume: 23, Issue:1

    Topics: Animals; Arterial Occlusive Diseases; Cell Division; Coronary Restenosis; Endothelium, Vascular; Homocysteine; Humans; Hyperhomocysteinemia; Hyperplasia; Muscle, Smooth, Vascular; Recurrence; Tunica Intima

2002

Trials

7 trial(s) available for homocysteine and Coronary Restenosis

ArticleYear
Factors Influencing Stent Restenosis After Percutaneous Coronary Intervention in Patients with Coronary Heart Disease: A Clinical Trial Based on 1-Year Follow-Up.
    Medical science monitor : international medical journal of experimental and clinical research, 2019, Jan-08, Volume: 25

    Topics: Aged; C-Reactive Protein; China; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Coronary Vessels; Female; Follow-Up Studies; Homocysteine; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Retrospective Studies; Risk Factors; Stents

2019
Culprit coronary lesions requiring percutaneous coronary intervention after vascular surgery often arise from in-stent restenosis of bare metal stents.
    Annals of vascular surgery, 2010, Volume: 24, Issue:5

    Topics: Aged; Angioplasty, Balloon, Coronary; Biomarkers; Chi-Square Distribution; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Elective Surgical Procedures; Female; Graft Occlusion, Vascular; Homocysteine; Humans; Male; Metals; Middle Aged; Preoperative Care; Prosthesis Design; Risk Assessment; Risk Factors; Stents; Time Factors; Treatment Outcome; United States; Vascular Surgical Procedures

2010
Effect of homocysteine-lowering therapy on restenosis after percutaneous coronary intervention for narrowings in small coronary arteries.
    The American journal of cardiology, 2003, May-15, Volume: 91, Issue:10

    Topics: Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Restenosis; Coronary Vessels; Double-Blind Method; Female; Folic Acid; Homocysteine; Humans; Logistic Models; Male; Middle Aged; Prospective Studies; Stents; Vitamin B 12; Vitamin B 6

2003
Folate therapy and in-stent restenosis after coronary stenting.
    The New England journal of medicine, 2004, Jun-24, Volume: 350, Issue:26

    Topics: Aged; Coronary Angiography; Coronary Disease; Coronary Restenosis; Coronary Vessels; Double-Blind Method; Drug Therapy, Combination; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Risk Factors; Stents; Treatment Failure; Vitamin B 12; Vitamin B 6

2004
Efficacy of folic acid therapy for prevention of in-stent restenosis: a randomized clinical trial.
    Archives of Iranian medicine, 2006, Volume: 9, Issue:2

    Topics: Coronary Angiography; Coronary Restenosis; Double-Blind Method; Female; Folic Acid; Homocysteine; Humans; Male; Middle Aged; Stents

2006
Relation of a common methylenetetrahydrofolate reductase mutation and plasma homocysteine with intimal hyperplasia after coronary stenting.
    Circulation, 2001, Apr-24, Volume: 103, Issue:16

    Topics: Alleles; Angioplasty, Balloon, Coronary; Coronary Artery Disease; Coronary Restenosis; Disease Progression; DNA Mutational Analysis; Female; Follow-Up Studies; Genotype; Homocysteine; Homozygote; Humans; Hyperplasia; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Multivariate Analysis; Mutation; Oxidoreductases Acting on CH-NH Group Donors; Risk; Stents; Tunica Intima; Ultrasonography, Interventional; Vascular Patency

2001
Decreased rate of coronary restenosis after lowering of plasma homocysteine levels.
    The New England journal of medicine, 2001, Nov-29, Volume: 345, Issue:22

    Topics: Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Coronary Vessels; Disease-Free Survival; Double-Blind Method; Drug Therapy, Combination; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Multivariate Analysis; Prospective Studies; Pyridoxine; Vitamin B 12

2001

Other Studies

14 other study(ies) available for homocysteine and Coronary Restenosis

ArticleYear
Effect of elevated homocysteine levels on clinical restenosis following percutaneous coronary intervention.
    Cardiology, 2002, Volume: 97, Issue:4

    Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Coronary Restenosis; Exercise Test; Female; Homocysteine; Humans; Male; Middle Aged; Myocardial Infarction; Recurrence; Statistics as Topic; Stroke Volume; Tomography, Emission-Computed, Single-Photon; Treatment Outcome

2002
The impact of plasma levels of C-reactive protein, lipoprotein (a) and homocysteine on the long-term prognosis after successful coronary stenting: The Global Evaluation of New Events and Restenosis After Stent Implantation Study.
    Journal of the American College of Cardiology, 2002, Oct-16, Volume: 40, Issue:8

    Topics: Aged; Angina, Unstable; Biomarkers; C-Reactive Protein; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Disease Progression; Female; Homocysteine; Humans; Lipoprotein(a); Male; Middle Aged; Prognosis; Proportional Hazards Models; Risk Assessment; ROC Curve

2002
Homocysteine and coronary angioplasty.
    The Journal of invasive cardiology, 2003, Volume: 15, Issue:9

    Topics: Angioplasty, Balloon, Coronary; Coronary Restenosis; Homocysteine; Humans

2003
Homocysteine status and polymorphisms of methylenetetrahydrofolate reductase are not associated with restenosis after stenting in coronary arteries.
    Arteriosclerosis, thrombosis, and vascular biology, 2003, Volume: 23, Issue:12

    Topics: Aged; Coronary Artery Disease; Coronary Restenosis; Female; Folic Acid; Follow-Up Studies; Genetic Predisposition to Disease; Genotype; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymorphism, Genetic; Postoperative Complications; Prosthesis Implantation; Stents; Thrombosis; Treatment Outcome; Vitamin B 12

2003
Restenosis in Intervened Coronaries with Hyperhomocysteinemia (RICH).
    American heart journal, 2003, Volume: 146, Issue:6

    Topics: Aged; Analysis of Variance; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Regression Analysis; ROC Curve; Stents

2003
Dietary prevention of post-angioplasty restenosis. From illusion and disillusion to pragmatism.
    Nutrition, metabolism, and cardiovascular diseases : NMCD, 2003, Volume: 13, Issue:6

    Topics: Angioplasty, Balloon, Coronary; Coronary Restenosis; Fatty Acids, Omega-3; Folic Acid; Homocysteine; Humans; Risk Factors; Vitamin B Complex

2003
High blood sugar, homocysteine boost artery-reclogging risks.
    Health news (Waltham, Mass.), 2004, Volume: 10, Issue:3

    Topics: Blood Glucose; Coronary Restenosis; Diabetes Mellitus, Type 2; Homocysteine; Humans; Risk Factors

2004
Folate therapy and in-stent restenosis.
    The New England journal of medicine, 2004, Sep-16, Volume: 351, Issue:12

    Topics: Angioplasty, Balloon, Coronary; Coronary Disease; Coronary Restenosis; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Stents; Vitamin B 6; Vitamin B Complex

2004
Homocysteine and its effects on in-stent restenosis.
    Circulation, 2005, Nov-08, Volume: 112, Issue:19

    Topics: Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Models, Biological; Myocardial Infarction; Stents

2005
Post-interventional homocysteine levels: failure as a predictive biomarker of in-stent restenosis.
    International journal of cardiology, 2006, Mar-22, Volume: 108, Issue:1

    Topics: Angioplasty, Balloon, Coronary; Biomarkers; Coronary Angiography; Coronary Disease; Coronary Restenosis; Female; Homocysteine; Humans; Male; Middle Aged; Postoperative Care; Predictive Value of Tests; Pregnancy; Statistics, Nonparametric; Stents

2006
Relation of homocysteine, vitamin B(12), and folate to coronary in-stent restenosis.
    The American journal of cardiology, 2002, Mar-01, Volume: 89, Issue:5

    Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Disease; Coronary Restenosis; Female; Folic Acid; Homocysteine; Humans; Male; Middle Aged; Predictive Value of Tests; Prospective Studies; Risk Factors; Stents; Vitamin B 12

2002
Heart lines. Taking aim at high homocysteine.
    Harvard heart letter : from Harvard Medical School, 2002, Volume: 12, Issue:7

    Topics: Angioplasty, Balloon, Coronary; Animals; Coronary Restenosis; Drug Combinations; Female; Homocysteine; Humans; Male; Nitric Oxide; Swine; Vitamin B Complex

2002
Association of plasma homocysteine with restenosis after percutaneous coronary angioplasty.
    European heart journal, 2002, Volume: 23, Issue:9

    Topics: Aged; Angioplasty, Balloon, Coronary; Biomarkers; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Coronary Vessels; Endpoint Determination; Female; Follow-Up Studies; Homocysteine; Humans; Incidence; Male; Middle Aged; Postoperative Complications; Prospective Studies; Recurrence; Severity of Illness Index; Statistics as Topic; Survival Analysis; Treatment Outcome

2002
Homocysteine and restenosis after percutaneous coronary intervention.
    Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 2001, Volume: 84 Suppl 3

    Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Restenosis; Coronary Stenosis; Female; Homocysteine; Humans; Male; Middle Aged; Risk Factors

2001